Abncov2 News Today

Bavarian Nordic’s non-adjuvanted COVID-19 vaccine candidate, ABNCoV2 , demonstrated a strong boosting effect, increasing the existing levels of SARS-CoV-2 neutralizing antibodies... | December 5, 2021

Bavarian Nordic reports encouraging data for covid-19 vaccine candidate A lab technician tests material inside a fume cabinet during Covid-19 polymerase chain reaction (PCR) test processing at a laboratory in the Dunkeld suburb of Johannesburg, South Africa, on Wednesday, Feb. 10, 2021. Scientists are concerned the South Africa coronavirus strain could be far more widespread in the U.K. than test results show, threatening plans to start lifting lockdown once vaccines have been deployed. Photogr...